Dust Mite Allergen Reduction Study
NCT00339690 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2019-12-16
Summary
This study will determine whether use of an in-home test kit results in decreased dust mite allergen levels in homes of children who are sensitive or allergic to dust mites. Dust mite allergens come from dust mites - microscopic spider-like animals that feed on house dust. Dust mites are common anywhere there is dust, such as in carpeting and beds. Some people are allergic to dust mite allergens and may develop asthma from living near them.
People who live in the Research Triangle Park area of North Carolina who have a child between 5 and 15 years old with a dust mite allergy or sensitivity may be eligible for this study. Participants must plan to remain in the same house for at least 12 months from the start of the study. At least half the floor of the child's room must be carpeted.
Participants are given materials on how to reduce dust mite allergens in their home. Study staff visit participants' homes three times over a 12-month period to ask questions about the home, home cleaning habits, and participants' experiences with home test kits (see below) for measuring dust mite allergen. At each visit, staff collect dust samples from the child's bedroom, the parents' bedroom, and the living room. The dust samples are analyzed in the laboratory for dust mite allergens and the results are given to the participants at the end of the study.
Participants are also given four home test kits for measuring dust mite allergen in the home. At the first home visit, staff instruct the participants on how to use the kits and answer any questions they may have. The kits are mailed at certain times during the study for the participants to use to measure allergen and send the results to the study investigators in a pre-paid addressed envelope.
A control group is given educational materials but no test kits.
Conditions
- Allergy
Interventions
- OTHER
-
MITE-T-FASTtest kit
The primary objective of this randomized intervention trial is to determine if the use of an inhome test kit, as an adjunct to education, results in greater reductions in dust mite allergen levels than the use of educational materials alone.
Sponsors & Collaborators
-
National Institute of Environmental Health Sciences (NIEHS)
lead NIH
Principal Investigators
-
Darryl C Zeldin, M.D. · National Institute of Environmental Health Sciences (NIEHS)
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 5 Years
- Max Age
- 15 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-06-06
- Primary Completion
- 2009-02-11
- Completion
- 2009-02-11
Countries
- United States
Study Locations
More Related Trials
-
Mite Asthma Pediatric Immunotherapy Trial
NCT03654976 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutaneous Immunotherapy in Adult Subjects With Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma Induced by House Dust Mite (HDM)
NCT06920771 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Evaluation of the Effect of a Nasal Allergen Challenge With Dermatophagoides Farinae Extract on Nasal Airway Inflammation in Allergic Individuals, Comparing E-cigarette Users to Cigarette Smokers and Non-smokers.
NCT03023397 ·Status: TERMINATED ·Phase: PHASE1
-
Assessment of Sublingual Immunotherapy in Children Allergic to House Dust Mites
NCT01052610 ·Status: UNKNOWN ·Phase: PHASE4
-
Skin Responses and T Cell Immunology After House Dust Mite Exposure in Sensitized Atopic Dermatitis Patients
NCT05019209 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607)
NCT01700192 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Multiple Nasal Exposures to House Dust Mite Allergen on Nasal and Body Inflammation and Airway Sensitivity
NCT00513487 ·Status: COMPLETED ·Phase: NA
-
Dose Ranging Study of SLIT Tablets of House Dust Mite Allergen Extracts (HDM) in Adults With HDM-associated Allergic Asthma
NCT01930461 ·Status: COMPLETED ·Phase: PHASE2
-
Repeated Nasal Challenge in Skin Prick-puncture Negative and Intradermal Positive Dust Mite Allergic Rhinitis Patients
NCT01179282 ·Status: COMPLETED ·Phase: NA
-
Interest of Nasal Provocation Tests for Diagnosis of House Mites Allergic Rhinitis
NCT04915352 ·Status: TERMINATED ·Phase: PHASE4
-
Efficacy and Safety Trial of the ALK HDM Tablet in House Dust Mite Allergic Subjects
NCT00389363 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
House Dust Mite Injection Immunotherapy in Elderly Patients.
NCT03209245 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of House Dust Mite Allergoid in the Treatment of Bronchial Asthma
NCT00263640 ·Status: COMPLETED ·Phase: PHASE3
-
Validation of an Environmental Exposure Chamber for Inhalation Studies With House Dust Mite Allergen in Patients With Allergic Rhinitis
NCT01275456 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic Rhinitis
NCT00674700 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Ramatroban/Montelukast Versus Montelukast/Placebo on the Early Allergic Reaction in Asthma Sensitive to House Dust Mite
NCT00311051 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Sensitivity and Specificity of Nasal Provocation Test in Allergic Rhinitis to House Dust Mites
NCT01485523 ·Status: COMPLETED
-
Efficacy of SLITone in House Dust Mite Allergic Patients
NCT00633919 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts in Adolescents
NCT01919554 ·Status: COMPLETED ·Phase: PHASE1
-
A One Year Trial Evaluating the Safety and Efficacy of the ALK House Dust Mite Allergy Tablet
NCT01454544 ·Status: COMPLETED ·Phase: PHASE3
-
House Dust Mite Treatment of Asthma. The MITRA Trial House Dust Mite Treatment of Asthma
NCT01433523 ·Status: COMPLETED ·Phase: PHASE3
-
Immunotherapy Administered Under the Tongue to Treat Dust Mite Allergy
NCT00200850 ·Status: COMPLETED ·Phase: NA
-
Mechanisms of Allergen Immunotherapy
NCT00001910 ·Status: COMPLETED
-
A Study to Assess the Safety, Tolerability and Immunological Response of ASP2390 in Adult Subjects Allergic to House Dust Mites
NCT04184895 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Aged 12-65
NCT07060885 ·Status: RECRUITING ·Phase: PHASE3